Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNA-seq of breast cancer cell lines post ligand treatment II
PubMed Similar studies Analyze with GEO2RSRA Run Selector
ATAC-seq, ChIP-seq and RNA-seq of breast cancer cell lines post ligand treatment
PubMed Similar studies
RNA-seq of breast cancer cell lines post ligand treatment I
ChIP-seq of ER in MCF-7 cells post ligand treatment
PubMed Similar studies SRA Run Selector
ATAC-seq of MCF-7 cells post ligand treatment
Genome-wide copy number profiling of MCF-7 and fulvestrant-resistant MCF-7/FR cells by SNP microarray.
PubMed Full text in PMC Similar studies
Fulvestrant withdrawal from fulvestrant-resistant MCF-7/FR cells
PubMed Full text in PMC Similar studies Analyze with GEO2R
Effect of RBP2 on MCF7 breast cancer cells (RNA-seq)
Analysis of breast cancer cells
PRO-seq analysis of estradiol, OP-1250, fulvestrant and 4OH-tamoxifen treatments at multiple timepoints in breast cancer cells
TET2 is a component of the ER complex and controls 5mC to 5hmC conversion at ER cis-regulatory regions
TET2 is a component of the ER complex and controls 5mC to 5hmC conversion at ER cis-regulatory regions [MMS/RRHP]
PubMed Full text in PMC Similar studies SRA Run Selector
TET2 is a component of the ER complex and controls 5mC to 5hmC conversion at ER cis-regulatory regions [ChIP-Seq]
TET2 is a component of the ER complex and controls 5mC to 5hmC conversion at ER cis-regulatory regions [RNA-Seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
High CDK6 protects cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant in estrogen receptor-positive metastatic breast cancer
Transcriptional profiling of clinically relevant SERMs and SERM/estradiol complexes in a cellular model of breast cancer
IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer [ATAC-Seq]
IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer
IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer (ChIP-Seq)
IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer (RNA-Seq)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on